Show simple item record

dc.contributor.authorLenglet, Annick
dc.contributor.authorKamau, Charity
dc.contributor.authorBoris, Hogema
dc.date.accessioned2018-07-27T13:14:16Z
dc.date.available2018-07-27T13:14:16Z
dc.date.issued2018-07
dc.identifier.urihttp://hdl.handle.net/10144/619225
dc.descriptionResearch Protocolen
dc.description.abstractOBJECTIVES 3.1 PRIMARY OBJECTIVES To estimate sero prevalence of anti-HEV antibodies (IgG and IgM) in different age groups in Am Timam, Chad 3.2 SECONDARY OBJECTIVES • To determine individual risk factors associated with different anti-HEV antibody status during an acute outbreak; • To determine household level risk factors associated with different anti-HEV antibody status during an acute outbreak; • To compare the sero prevalence of anti-HEV antibodies (IgG and IgM) in different age groups at two different time periods during an acute HEV outbreak to inform our understanding of viral transmission dynamics in a population in this context; • To determine sero prevalence in different age groups of other jaundice causing agents (malaria, hepatitis A, B and C, leptospirosis and arboviral diseases such as yellow fever, viral haemorrhagic fever, Dengue and Rift valley fever; • To compare dried blood spots (DBS) with blood samples for detection of HEV IgM and IgG and HEV RNA through PCR; • To compare oral swabs with blood samples for the detection of HEV IgM and IgG and HEV RNA through PCR.
dc.language.isoenen
dc.rightsThese materials can be used, adapted and copied as long as citation of the source is given including the direct URL to the material. This work is licensed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0/ https://i.creativecommons.org/l/by/4.0/88x31.pngen
dc.subjectsero-prevalenceen
dc.subjectantibodiesen
dc.subjecthepatitis Een
dc.subjectacute outbreaken
dc.titleDetermining sero-prevalence of antibodies against Hepatitis E during an acute outbreak scenario.en
dc.typeOtheren
dc.contributor.departmentMSF-OCAen
refterms.dateFOA2019-02-21T13:48:26Z
html.description.abstractOBJECTIVES 3.1 PRIMARY OBJECTIVES To estimate sero prevalence of anti-HEV antibodies (IgG and IgM) in different age groups in Am Timam, Chad 3.2 SECONDARY OBJECTIVES • To determine individual risk factors associated with different anti-HEV antibody status during an acute outbreak; • To determine household level risk factors associated with different anti-HEV antibody status during an acute outbreak; • To compare the sero prevalence of anti-HEV antibodies (IgG and IgM) in different age groups at two different time periods during an acute HEV outbreak to inform our understanding of viral transmission dynamics in a population in this context; • To determine sero prevalence in different age groups of other jaundice causing agents (malaria, hepatitis A, B and C, leptospirosis and arboviral diseases such as yellow fever, viral haemorrhagic fever, Dengue and Rift valley fever; • To compare dried blood spots (DBS) with blood samples for detection of HEV IgM and IgG and HEV RNA through PCR; • To compare oral swabs with blood samples for the detection of HEV IgM and IgG and HEV RNA through PCR.


Files in this item

Thumbnail
Name:
1)_Protocol_Sero_Survey_HEV_Am ...
Size:
2.787Mb
Format:
Microsoft Word 2007
Description:
Research Protocol

This item appears in the following Collection(s)

Show simple item record